Who invested in Aelin Therapeutics?
Aelin Therapeutics's investors include Novartis, PMV and Boehringer Ingelheim Venture Fund.
Who invested in Aelin Therapeutics
Funding summaryUpdated 26 Oct 2026
$32Mraised across 1 round since 2017, from 1 source
- Latest round
- Series A, $32MDec 2017
- Investors
- 3
The rounds
- Dec 2017
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about Aelin Therapeutics
How much has Aelin Therapeutics raised?
Aelin Therapeutics has raised $32M across 1 round since 2017.
When did Aelin Therapeutics last raise?
Aelin Therapeutics's most recent round was a Series A of $32M in Dec 2017.
What was Aelin Therapeutics's biggest round?
Its most recent round, $32M in Dec 2017, is also its largest on record.
Who backed Aelin Therapeutics first?
Aelin Therapeutics's first round on record, in Dec 2017, was backed by Novartis, PMV and Boehringer Ingelheim Venture Fund.
What stage is Aelin Therapeutics at?
Aelin Therapeutics's latest named round is a Series A, in Dec 2017.
Companies like Aelin Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.